Skip to content

Blogs

Blog posts from individual members

0 Topics 0 Posts
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
  • PAAB Forum Quarterly Review, eFiles Tag and CEI Report Q4/2024

    1
    1 Votes
    1 Posts
    502 Views
    No one has replied
  • 1 Votes
    4 Posts
    303 Views
    Jennifer CarrollJ
    Hey @constance. Please find response below. Phase 1 is not complete. There will be rounds of consultation with industry prior to launching to ensure that we are developing as efficiently and in the most supportive manners. Please stay tuned as we look for assistance in finalizing technical validations, user testing, and ensuring adequate support resources are in place. We anticipate these steps will be completed by the end of Q2 and will communicate a go live date as we approach completion. Manufacturers have been informed about the initiative through communications and the townhall. PAAB has also spoke to this initiative at a number of conferences. We have also invited manufacturers to reach out with specific questions especially surrounding privacy and security. We anticipate that the level of understanding may vary. The purpose of the debrief meeting is to ensure that both agencies and manufacturers have a shared understanding of the initiative while also inviting feedback and suggestions as we develop and scale. As their agencies, your role is pivotal in supporting their implementation efforts, but the debrief aims to equip everyone with the necessary context and clarity to move forward confidently. Please rest assured that we will develop training and guidance related to the new policies and procedures to ensure both agencies and manufacturers are equipped with the knowledge they need to successfully utilize the new features’. We anticipate that there will be a mixture of manufacturers alone and agencies in collaboration with the manufacturers participating in these meetings. Who participates is at the discretion of the manufacturer. If agencies have agency specific questions, we are also happy to set up these meetings. It may also be possible that the first meeting will be solely with the manufacturer and then they may opt to bring in agencies as it becomes necessary. Please note that currently, these debriefs are not training sessions for the use of new features. These debriefs are intended to discuss security, privacy, and whether/how proprietary manufacturer generated content will be used as we progress through Phase 1 and 2 of the initiative”. We hope that helps. Thank you for the questions and continued engagement.
  • PAAB Forum and Quarterly Review and eFiles Tag and CEI Report Q3/2024

    1
    0 Votes
    1 Posts
    199 Views
    No one has replied
  • 1 Votes
    1 Posts
    350 Views
    No one has replied
  • PAAB eFiles Tag and CEI Report 2024

    tag cei
    1
    1 Votes
    1 Posts
    1k Views
    No one has replied
  • 1 Votes
    1 Posts
    1k Views
    No one has replied
  • PAAB eFiles Tag and CEI Report 2023

    external tags & tickets cei
    6
    1 Votes
    6 Posts
    2k Views
    Jennifer CarrollJ
    Hello @Manufacturer and @Agency . Please find uploaded the completed Tag report and CEI report for Q4 of 2023. Please let us know if you have any questions. Have a great week.
  • 0 Votes
    1 Posts
    679 Views
    No one has replied
  • 1 Votes
    1 Posts
    450 Views
    No one has replied
  • Creative Imagery Committee

    6
    1 Votes
    6 Posts
    2k Views
    Jennifer CarrollJ
    Hey @constance Always happy to have more examples to discuss. If you’d like to send examples for the group to discuss, please email them to me at jenniferc@paab.ca. What we would require is: • Confirmation from the sponsor that the content can be discussed and shared with the committee • Confirmation from the sponsor that all content discussed can be shared externally as part of training documents • Any information you can share about the campaign such as “what are the primary and secondary messages the campaign hopes to convey” • If the creative went through iterations, provide the iterations (iterations with PAAB or outside of PAAB such as through the internal Canadianization process or within the agency). • If you have internally developed creative that was not part of a sponsor project that you think would make for good discussions, we can look at those as well The committee will not be evaluating the merits of any past decisions or evidence and in most cases the discussions will be brand agnostic so that the discussion stays focused on assessing creative elements. As the committee is meeting in early January, we'd encourage sending content before then.
  • RWE Committee Update and Launch Date

    external rwe timeline committee
    5
    2
    1 Votes
    5 Posts
    4k Views
    V
    @jennifer-carroll Thank you for the information.
  • PAAB eFiles Tag and CEI Report Q2 - 2023

    newsletter tags & tickets cei
    4
    0 Votes
    4 Posts
    554 Views
    Jennifer CarrollJ
    @costeap Absolutely we can add guidance on why tags were deemed invalid. Great suggestion. We’ll add it in to Q3. Thank you for the feedback.
  • Update: Formulary Review Practices

    external formulary formulary criteria
    6
    2 Votes
    6 Posts
    3k Views
    Jennifer CarrollJ
    Hello @dmauri PAAB practice has been to accept communications from formulary bodies to the manufacturer which confirm listing and criteria in the absence of published coverage criteria. In the absence of these letters, we have accepted an attestation from the sponsor that confirms the EAP listing and that the government/ministry has no objection to the marketing of this criteria. The client can proceed with submitting pieces which communicate the listing and criteria.
  • PAAB Forum Quarterly Review - Q1/2023

    external formlary rwe creative imagery cei
    1
    2 Votes
    1 Posts
    476 Views
    No one has replied
  • 1 Votes
    1 Posts
    456 Views
    No one has replied
  • PAAB eFiles Tag Report 2022

    tags & tickets
    1
    0 Votes
    1 Posts
    426 Views
    No one has replied
  • PAAB Forum Quarterly Review - Q3/2022

    external newsletter
    1
    0 Votes
    1 Posts
    478 Views
    No one has replied
  • 1 Votes
    1 Posts
    665 Views
    No one has replied
  • ARO Launch Figures - September 2022

    aro
    1
    1
    0 Votes
    1 Posts
    440 Views
    No one has replied
  • PAAB Forum Quarterly Review - Q2/2022

    external newsletter
    1
    0 Votes
    1 Posts
    2k Views
    No one has replied